Today’s value-based reimbursement programs require hospitals and health systems to shorten the length of time patients are hospitalized, reduce readmissions and improve quality of care. When post-acute infusion therapy is required, these challenges can be heightened, but are readily achievable for individuals who are relatively healthy, stable and financially secure. However, the risk of poor outcomes increases significantly for those who: are sicker and have comorbidities; have limited caregiver support; lack transportation options; or have Medicare without a Medigap plan, a high-deductible commercial plan or are uninsured or underinsured.
Ensuring all patients can be successfully transitioned to post-acute care as soon as possible requires a forward-thinking infusion provider that can offer comprehensive solutions for all patient types. Option Care’s highly trained and experienced multi-disciplinary teams of Clinical Care Transition Specialists, infusion nurses, pharmacists, dietitians, patient registration and reimbursement professionals ensure any patient that is able to go home, can go home by offering the following support:
For example, Option Care worked with the family of one patient who needed therapy for complex medical issues, but ran out of hospital days covered by his insurance plan and couldn’t afford the copay for post-acute care. Rather than face thousands of dollars in out-of-pocket costs, Option Care helped arrange financial assistance allowing him to be discharged from the hospital and get his medicine at home.
Option Care also supports hospitals and health systems as a valued post-acute infusion partner with extensive payer coverage, demonstrated quality results and access to a wide range of limited distribution specialty infusion drugs that can be delivered in a more affordable setting.
Many patients require infusion treatment upon discharge from the hospital. Partnering with a quality infusion provider ensures effective care transitions for all individuals, mitigating the risk for hospitals and health systems and ensuring patients have access to the treatment they need.
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen